Raymond James Financial Inc. Makes New Investment in Blueprint Medicines Co. (NASDAQ:BPMC)
Raymond James Financial Inc. acquired a new position in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) during the fourth quarter, Holdings Channel reports. The fund acquired 241,966 shares of the biotechnology company’s stock, valued at approximately $21,104,000. A number of other hedge funds have also recently bought and sold shares of BPMC. Quarry […]
Raymond James Financial Inc. acquired a new position in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) during the fourth quarter, Holdings Channel reports. The fund acquired 241,966 shares of the biotechnology company’s stock, valued at approximately $21,104,000. A number of other hedge funds have also recently bought and sold shares of BPMC. Quarry […]
